【摘 要】
：
Herein,the rationale and supporting evidence for the promise of developing K+/Cl-co-transporter-2 (KCC2) neuromodulatory therapies for spinal cord injury (SCl) is discussed.SCI is commonly a life-changing,unforeseen neurotrauma that has devastating conseq
【机 构】
：
AXONIS Therapeutics,Inc.,LabCentral,Cambridge,MA,USA
论文部分内容阅读
Herein,the rationale and supporting evidence for the promise of developing K+/Cl-co-transporter-2 (KCC2) neuromodulatory therapies for spinal cord injury (SCl) is discussed.SCI is commonly a life-changing,unforeseen neurotrauma that has devastating consequences for the injured person,their families and society as a whole.Because less than 1％ of patients have a complete recovery,the vast majority of people after SCl have significant disabilities and can be entirely dependent upon others for assistance in their activities of daily living.The socioeconomic costs are a significant global burden,with SCI often occurring in adults during their peak earning years.Currently,there are no approved drugs that improve functional outcomes for people with SCI.Therefore,SCI commonly leads to a lifetime of disability,and new therapeutic approaches are urgently needed.
其他文献
The human body is populated by a large number of microbial colonies,with an estimated 10-100 trillion microbes.The total genome size of human microbial colonies by far overwhelms the size of the host\'s genome.This heterogenous group of microbial coloni
The association between traumatic brain injury (TBI) and an increased risk of neurodegeneration has been recognized for some decades now (Faden and Loane,2015),with recent evidence suggesting that a history of TBI,either as repeated concussive/mild TBI in
Introduction:In the 1680s,Antonie van Leewenhoek was the first to observe the differences in the human gut microbiome versus the oral cavity diversity,and it led to the birth of a new term,“microbiota”.
In a symbiotic and mutualistic manner,the gut microbiota strongly influences many vital aspects of host physiology,biology,repair,and regeneration.The role of microbiota in many areas of regenerative medicine is just beginning to emerge,but it is under-re
Alzheimer\'s disease (AD) is a neurodegenerative disease that is characterized by an age-dependent progressive decline of memory,impairment of cognitive functions and changes in personality and behavior.Despite the improvement in understanding of the me
Childhood maltreatment (CM) has been consistently linked with numerous detrimental outcomes concerning physical and psychological health.However,few studies have explored vulnerability to neurological disorders after CM.Early life adversity,in the form of
Late stage blindness and visual impairment (BVl) affects over 400 million adults worldwide.These disabilities severely impact the ability of adults to function independently,reduce their quality of life,and worsen socio-economic burdens on health care sys
Alzheimer\'s disease (AD) is the most common cause of dementia in the elderly.Unfortunately,there are no effective therapies currently available for prevention and treatment of AD.As it is clear now,the etiology of AD is multifactorial and complex.This
A recent study by McDonald et al.(2021) focused on how peripheral glucose metabolism and handling are compromised in amyotrophic lateral sclerosis (ALS).Dysfunctions in glucose and energy metabolism have been identified in transgenic mouse models and pati
The mammalian central nervous system(CNS) is highly complex,with a vast array of processes and interactions occurring in a dynamic and often transient manner.How these processes are combined to regulate our behavior remains poorly understood.This has in t